Application

15012445 · NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS

Filed 2016-02-01 · Granted · Patent 9718819 (2017-08-01) The official file ↗The patent and its PDF ↗ · Art unit 1628 · Examiner Jean P Cornet Hard · CPC C07D 401/14 · Merck Sharp & Dohme Corp. · MERCK

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

1.6 mo

to disposition 18.0 mo

Statutes raised

103 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.